MedTrace Logo

Electromyography Signals as Biomarkers for Parkinson's Disease

NCT02168504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-10-08

No results posted yet for this study

Summary

A simple, painless and reliable method to detect Parkinson's disease at an early stage is very important to patients, doctors and researchers. Doctors want to help patients early, and scientists want to select patients for their research who will help in development of better drugs. We hope that the changes in electrical activity of hand muscles during handwriting will help in early detection of this disease.

Conditions

Sponsors & Collaborators

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • Norconnect Inc

    lead INDUSTRY

Principal Investigators

  • Michael Linderman, M. Sc. Eng · Norconnect Inc

Eligibility

Min Age
25 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02168504 on ClinicalTrials.gov